News

Molecular Instruments Enhances HCR™ Imaging Platform with New Releases

Molecular Instruments Enhances HCR™ Imaging Platform with New Releases

Molecular Instruments Unveils HCR™ Gold and HCR™ Pro

Molecular Instruments® (MI) has launched two exciting product lines, HCR™ Gold and HCR™ Pro, designed to greatly enhance the HCR™ imaging platform. This innovative advancement facilitates academic research and biopharma drug development by providing versatile imaging solutions for both manual and automated workflows. The newly expanded platform supports a variety of assays for simultaneous RNA and protein imaging with sample morphology maintained to the highest standards.

Introducing the HCR™ Imaging Platform

The foundational technology behind HCR™ imaging has transformed how researchers approach multiplex and quantitative RNA fluorescence in situ hybridization (RNA-FISH). This platform introduces unprecedented capabilities such as simple multiplexing and quantitative imaging, delivering the sensitivity required for challenging samples. The HCR™ platform offers unique research opportunities for imaging thick samples, including whole-mount vertebrate embryos and thick brain slices, broadening the horizons of biological research.

Advanced Fiber Using Dynamic Nanotechnology

The HCR™ imaging platform utilizes advanced dynamic nanotechnology, allowing small amplification components to penetrate biological samples seamlessly. Once inside the sample, these components trigger the growth of bright amplification polymers precisely where needed. This technology is instrumental for both the HCR™ Gold product line, focused on manual workflows, and the HCR™ Pro line, which supports automated workflows.

HCR™ Gold RNA-FISH/IF: Elevating Performance

The HCR™ Gold RNA-FISH assays have made significant improvements in enhancing signal-to-background ratios across various sample types. Notably, the 10-plex capability allows simultaneous imaging of up to 10 RNA and/or protein targets. This feature elevates the HCR™ Gold offerings, establishing a new standard for imaging delicate and whole-mount specimens that do not suit conventional imaging methods.

Streamlined Imaging with 10-Plex

With the HCR™ Gold 10-plex system, researchers can efficiently acquire images without repetitive staining and imaging cycles, significantly reducing the time and effort typically associated with traditional multiplexing techniques. This approach eliminates the cumbersome steps of repeated imaging, making it ideal for studies requiring complex data.

The HCR™ Pro RNA-CISH/RNA-FISH Workflow

The HCR™ Pro line sets a new benchmark in imaging methodology with its entirely protease-free workflows. This design maintains sample integrity while enabling high-quality RNA in situ hybridization (RNA-CISH/RNA-FISH) in tissue sections, both fixed and fresh variants, essential for biopharmaceutical development processes. Unlike conventional methods that rely on protease pretreatment, risking damage to tissue integrity, the HCR™ Pro ensures that protein targets remain intact during the imaging process.

Innovative Compatibility and Insights

Incorporating unprecedented workflow compatibility, HCR™ Pro enables simultaneous imaging of two RNA targets along with additional protein targets within a single specimen, preserving the quality necessary for both academic and clinical settings. This innovative approach not only enhances research efficiency but also optimizes the use of valuable patient samples.

The HCR™ HiFi Probe Promise

Both the HCR™ Gold and HCR™ Pro kits utilize HCR™ HiFi Probes, which provide automatic background suppression through a unique trigger mechanism, further enhancing imaging reliability. MI offers an Infinite Catalog of HCR™ HiFi Probes, adapting to any target RNA across diverse biological organisms, all without additional design costs.

About Molecular Instruments

Molecular Instruments® specializes in the development and synthesis of molecular kits, powered by the groundbreaking HCR™ imaging platform. Their technologies are vital for a range of applications spanning academic research, drug development, synthetic biology, clinical pathology, and diagnostics, positioning the company as a leader in innovative imaging solutions.

Frequently Asked Questions

What are the key benefits of the HCR™ Gold and HCR™ Pro product lines?

The HCR™ Gold enhances signal clarity and allows for imaging of multiple targets simultaneously, while the HCR™ Pro provides a protease-free workflow compatible with existing assays.

How does the HCR™ imaging platform improve RNA and protein imaging?

By utilizing dynamic nanotechnology, the HCR™ platform enables better sample penetration and promotes high signal-to-background ratios, allowing for clearer, more accurate images.

What makes the 10-plex capability unique?

The 10-plex capability allows imaging of up to 10 targets simultaneously without the need for multiple rounds of staining, saving time and resources.

What are the applications of MI's HCR™ imaging technologies?

MI's technologies are widely used in academic research, biopharma drug development, clinical pathology, and diagnostics, enhancing various scientific investigations and discoveries.

Who can benefit from the HCR™ imaging platform?

Academic researchers and biopharma developers can significantly benefit from the HCR™ imaging platform, which supports high-resolution imaging with preserved sample morphology.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 442

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 124

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Cars.com Inducement Awards: New CPO Earns Stock Boost

Updated Category News Views 57

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 337

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 32

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 212

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 397

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 117

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 137

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 93

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Excellence: Inspiring Driver Education Teachers Recognized

Updated Category News Views 104

Recognizing Outstanding Driver Education Teachers In a significant tribute to commitment, four exceptional driver education teachers have been recognized for their exemplary work. This prestigious award, known as Teachers of Excellence, is presented by the National Road Safety Foundation in collaboration with the American Driver & Traffic Safety Education Association...

Continue Reading
Understanding the Proposed Settlement for CarLotz, Inc. Investors

Updated Category News Views 378

Settlement Overview for CarLotz, Inc. Investors The legal developments concerning CarLotz, Inc. and Acamar securities have prompted significant attention from investors and stakeholders. This notice serves to inform everyone involved in the securities market about a proposed settlement that could affect many. As a result of ongoing litigation, a court hearing has been...

Continue Reading
Whales Stockpile Dogecoin Amid Market Uncertainty: Insights Explained

Updated Category News Views 186

Whales Are Accumulating Dogecoin Amid Price Fluctuations In a surprising turn of events, whale investors are making significant moves in the Dogecoin market. Even as the price fluctuates, these large holders have taken the opportunity to accumulate a staggering 150 million DOGE. This behavior raises questions about what these investors might be anticipating for Dogecoin's...

Continue Reading
AEON and United Stables Team Up for Next-Gen Payments

Updated Category News Views 160

AEON Forms Strategic Partnership with United Stables AEON, an innovative payment and settlement platform crafted for the evolving AI-driven economy, has announced an exciting collaboration with United Stables ($U). This partnership aims to revolutionize how payments are processed in the real world by integrating United Stables’ next-generation stablecoin, designed for...

Continue Reading
Understanding the Impact of Anti-Americanism on Global Brands

Updated Category News Views 188

The Rising Challenge of Anti-Americanism for U.S. Brands In today's global marketplace, the influence of international sentiment on brands is undeniable. Recent studies have highlighted a significant increase in anti-American feelings, which poses a serious challenge for American companies looking to thrive abroad. According to research conducted by the American Marketing...

Continue Reading